Search results
Pacira (PCRX) Preliminary '23 Revenues Solid, Exparel Strong
Zacks via Yahoo Finance· 4 months agoPacira BioSciences, Inc. PCRX reported preliminary total revenues (unaudited) of $675.0 million for...
Pacira (PCRX) Q4 Earnings Match, Exparel Sales Drive Revenues
Zacks via Yahoo Finance· 2 months agoPacira BioSciences, Inc. PCRX reported fourth-quarter 2023 adjusted earnings of 89 cents per share,...
Pacira's (PCRX) Q4 Earnings Match Estimates, Revenues Fall
Zacks via Yahoo Finance· 1 year agoPacira BioSciences, Inc. PCRX reported fourth-quarter 2022 adjusted earnings of 80 cents per share,...
Pacira (PCRX) Q2 Earnings and Sales Miss, '23 View Updated
Zacks via Yahoo Finance· 9 months agoPacira BioSciences, Inc. PCRX reported second-quarter 2023 adjusted earnings of 78 cents per share,...
Endo (ENDP) Inks Deal for Osteoarthritis Knee Pain Drug
Zacks via Yahoo Finance· 2 years agoEndo (ENDP) collaborates with Taiwan Liposome to commercialize TLC599, an extended and controlled...
Why Is Pacira (PCRX) Down 11.8% Since Last Earnings Report?
Zacks via Yahoo Finance· 11 months agoA month has gone by since the last earnings report for Pacira (PCRX). Shares have lost about 11.8%...
The Best Beauty Looks at the 2023 Golden Globes
People via Yahoo News· 1 year agoDotdash Meredith and Yahoo Inc. may earn commission or revenue on some items through the links below. Todd Williamson/NBC/NBC via Getty (3) In addition...
Firm announces development of room-temperature mRNA delivery system
United Press International via Yahoo News· 3 months agoSouth Korea’s Cha Vaccine Institute said it has developed an mRNA delivery system designed to work...
What's Going On With Moleculin Biotech Stock Today?
Benzinga via Yahoo Finance· 1 year agoMoleculin Biotech Inc (NASDAQ: MBRX) announced that preclinical data regarding its next-generation anthracycline, Annamycin, was presented at the...
Don’t Wait for US Legalization, Here Are 4 Cannabis Stocks to Consider Right Now
FX Empire via Yahoo Finance· 2 years agoEarlier in April, the Marijuana Opportunity Reinvestment and Expungement Act (MORE) was narrowly...
